Please select the eligibility criteria that correspond to the clinical trial below.
Title: Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis
Brief Summary: The study will examine whether the provision of psychosocial support services for cancer patients in acute care can be optimized by the use of a structured combination of screening procedures with physician interviews and structured patient pathways.

There is strong evidence that a third of all cancer patients in acute care are suffering from mental health conditions and that a third expresses the need for professional psycho-oncological support.

However, physicians and nurses do not always identify these patients in need for support. Screening questionnaires are significantly better to identify distressed patients however the use of screenings alone does not necessarily improve the patients' emotional well-being.

Purpose of this study is to evaluate a psychosocial stepped care model which aims to decrease the patients' distress.


Options:
A: Inclusion Criteria:

* patients in acute care for cancer
* written informed consent
* 18 years and older
* ability to complete questionnaires

Exclusion Criteria:

- insufficient command of German
B: Inclusion Criteria:

* Female between 18 and 75 years old,
* Being diagnosed with a first primary non-metastatic invasive breast carcinoma, that has been histologically conﬁrmed,
* Having been operated and requiring the prescription of an adjuvant treatment (chemotherapy, hormonotherapy, radiotherapy),
* Whose adjuvant treatment will be prescribed (for hormone therapy) or carried out (for chemotherapy and radiotherapy) in one of the investigating centers,
* Being able to practice adapted physical activity and providing a medical certiﬁcate of no contraindications to exercise issued by the investigator physician, the general practitioner, or the referring physician,
* Available and willing to participate in the study for the duration of the interventions and follow-up,
* Using a personal smartphone compatible with the application (iOS operating system from version 9.3, Android operating system from version 5.0, no Microsoft operating system) and having Internet access on a computer,
* Able to understand, read, and write French,
* Affiliated with a social security scheme,
* Having dated and signed an informed consent.

Exclusion Criteria:

* Woman with recurrent, metastatic, or inflammatory breast cancer,
* Personal history or co-existence of another primary cancer (except of in situ cancer regardless of the site and/or basal cell skin cancer and/or non-mammary cancer in complete remission for more than 5 years),
* Presenting a contraindication to exercise according to the investigator (such as cardiorespiratory or bone pathologies, non-stabilized chronic diseases such as diabetes, malnutrition, etc.),
* In a state of severe malnutrition according to the criteria of the French National Health Authority (i.e., in women ≤ 70 years: weight loss ≥ 15% in 6 months or ≥ 10% in 1 month; in women \> 70 years: weight loss ≥ 15% in 6 months or ≥ 10% in 1 month, and body mass index \< 18 kg/m²),
* Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
* Participating in simultaneous physical activity studies,
* Deprived of their liberty by court or administrative decision,
* Pregnant or breastfeeding or of childbearing age without effective contraception for the duration of the study.
C: Inclusion Criteria:

* Patients with either diagnosis of AML in first or second remission, in first untreated relapse (blast count in marrow \< 30%); ALL in first or second remission, in first untreated relapse (blast count in marrow \< 30%); CML in first chronic phase, in first accelerated phase (total blast and promyelocytes in marrow and or peripheral blood \< 30%) or MDS (excluding RAEB-t).
* Age between 18 and 55 years.
* ECOG performance status between 0,1 or 2.
* HLA-identical sibling donor.
* Written informed consent.

Exclusion Criteria:

* Serum creatinine more than 10% above the normal range for the centre.
* Left ventricular size and function abnormal.
* DLCO \< 50%.
* Bilirubin \> 2mg/dL (34.2 µmol/L).
* Splenectomised or splenic irradiation.
* Psychiatric, addictive, or any other disorder, which compromises ability to give truly informed consent for participation in this study.
* Currently receiving non-licensed drugs which may affect GVHD or engraftment.
* Pregnant or lactating women.
* Known sensitivity to E.coli derived products.
* HIV positive.
* Previously received BM/PBPC transplant.
D: Inclusion Criteria:

* Adult(≥ 20 years)
* Within 24 months of completion of primary treatment with curative intent (Surgery, radiotherapy, chemotherapy)
* Breast, cervical, colorectal (except rectal cancer), lung, and stomach cancer
* More than two problematic areas among exercise, diet (Fruit \& Vegetable: F\&V), and posttraumatic growth(exercise \< 150min/week, ≥ 3mets, F\&V \< 5/day, PTGI \< 71)

Exclusion Criteria:

* Evidence of secondary tumor, metastasis and recurrence
* Patients undergoing or planning surgery, radiation therapy or chemotherapy
* Not Korean speaking and reading (Not communication with Korean)
* Not understanding of the study purpose and not written informed consent
* Participants who have an similar study experience
* Major health problem in which exercise/nutrition intervention is contraindicated at the discretion of clinician; cardiovascular disease (congestive heart failure, angina), pulmonary disease (chronic obstructive pulmonary disease, restrictive pulmonary disease), uncontrolled hypertension, poorly controlled diabetes and severe musculoskeletal disease and so on
* Sign of infection (body temperature ≥ 37.2℃ or WBC ≥ 11,000)
* Being pregnant
* Thrombocytopenia (platelet count ≤ 100,000/mcl)
* Anemia (Hb ≤ 10g/dL)
* SGOT or SGPT \> 40 IU/L
* Creatinine \> 1.2 mg/dL
* Severe psychiatric disorder (psychotic disorder, major depression and so on) or suicidal tendencies
* dyspnea

Answer: A